American Academy of CME

A Collaborative, Sophisticated Approach to Accredited Continuing Education

Our policies and procedures provide a roadmap for how we provide accredited continuing education.

CE Activities > CE Activities
New Guidance to Diagnose and Treat Tumor-induced Osteomalacia (TIO)

Physicians

American Academy of CME, Inc., designates this enduring material for a maximum of 0.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Other HCPs:

Other members of the care team will receive a certificate of participation.


Expires on: November 30, 2024


 Rare Diseases

Myasthenia Gravis Research Highlights: AAN 2024

Physicians

American Academy of CME, Inc., designates this enduring material for a maximum of 0.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.


Expires on: June 30, 2025


 Rare Diseases

Myasthenia Gravis and the Complement System: Treatment Options

Physicians

American Academy of CME, Inc., designates this enduring material for a maximum of 0.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Other HCPs:

Other members of the care team will receive a certificate of participation.


Expires on: December 18, 2024


 Rare Diseases

Myasthenia Gravis and the Complement System: Pathophysiology

Physicians

American Academy of CME, Inc., designates this enduring material for a maximum of 0.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Other HCPs:

Other members of the care team will receive a certificate of participation.


Expires on: December 18, 2024


 Rare Diseases

Multiple Myeloma Care: Translating Evolving Practices to Oncology Nurses in Community Settings

Nurse Practitioners and Nurses:

American Academy of CME, Inc., designates this educational activity for 1.0 ANCC contact hour, includes 0.75 pharmacology hour.

Provider approved by the California Board of Registered Nursing.

California BRN Provider # CEP16993


Expires on: July 2, 2025


 Oncology

Page 3 of 11